These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 26776847)

  • 1. Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base.
    Johnston WC; Hoen HM; Cassera MA; Newell PH; Hammill CW; Hansen PD; Wolf RF
    HPB (Oxford); 2016 Jan; 18(1):21-8. PubMed ID: 26776847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved long-term outcomes after resection of pancreatic adenocarcinoma: a comparison between two time periods.
    Serrano PE; Cleary SP; Dhani N; Kim PT; Greig PD; Leung K; Moulton CA; Gallinger S; Wei AC
    Ann Surg Oncol; 2015 Apr; 22(4):1160-7. PubMed ID: 25348784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency ablation of liver metastasis in patients with locally controlled pancreatic ductal adenocarcinoma.
    Park JB; Kim YH; Kim J; Chang HM; Kim TW; Kim SC; Kim PN; Han DJ
    J Vasc Interv Radiol; 2012 May; 23(5):635-41. PubMed ID: 22525021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-year and five-year outcomes of surgical resection for pancreatic ductal adenocarcinoma: Long-term experiences in one medical center.
    Hsu CP; Hsu JT; Liao CH; Kang SC; Lin BC; Hsu YP; Yeh CN; Yeh TS; Hwang TL
    Asian J Surg; 2018 Mar; 41(2):115-123. PubMed ID: 28010955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved survival after palliative resection of unsuspected stage IV pancreatic ductal adenocarcinoma.
    Kim Y; Kim SC; Song KB; Kim J; Kang DR; Lee JH; Park KM; Lee YJ
    HPB (Oxford); 2016 Apr; 18(4):325-31. PubMed ID: 27037201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of facility type on survival outcomes after pancreatectomy for pancreatic adenocarcinoma.
    Chu QD; Zhou M; Peddi P; Medeiros KL; Zibari GB; Shokouh-Amiri H; Wu XC
    HPB (Oxford); 2017 Dec; 19(12):1046-1057. PubMed ID: 28967535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic cancer metastatic to a limited number of lymph nodes has no impact on outcome.
    Baldwin S; Kukar M; Gabriel E; Attwood K; Wilkinson N; Hochwald SN; Kuvshinoff B
    HPB (Oxford); 2016 Jun; 18(6):523-8. PubMed ID: 27317957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.
    Riediger H; Keck T; Wellner U; zur Hausen A; Adam U; Hopt UT; Makowiec F
    J Gastrointest Surg; 2009 Jul; 13(7):1337-44. PubMed ID: 19418101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.
    Liu L; Katz MH; Lee SM; Fischer LK; Prakash L; Parker N; Wang H; Varadhachary GR; Wolff RA; Lee JE; Pisters PW; Maitra A; Fleming JB; Estrella J; Rashid A; Wang H
    Am J Surg Pathol; 2015 Oct; 39(10):1395-403. PubMed ID: 26200098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study.
    Gao H; Liu T; Wang G; Gao Y; Yin L; Peng Y; Lyu N; Zhang K; Gao W; Wu J; Jiang K; Wei J; Miao Y
    Langenbecks Arch Surg; 2019 Mar; 404(2):175-182. PubMed ID: 30826926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma.
    Lewis R; Drebin JA; Callery MP; Fraker D; Kent TS; Gates J; Vollmer CM
    HPB (Oxford); 2013 Jan; 15(1):49-60. PubMed ID: 23216779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Results of Pancreatic Resections and Long-Term Survival for Pancreatic Ductal Adenocarcinoma: A Single-Institution Experience.
    Seppänen H; Juuti A; Mustonen H; Haapamäki C; Nordling S; Carpelan-Holmström M; Sirén J; Luettges J; Haglund C; Kiviluoto T
    Scand J Surg; 2017 Mar; 106(1):54-61. PubMed ID: 27130378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
    Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP
    Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.
    Glazer ES; Rashid OM; Pimiento JM; Hodul PJ; Malafa MP
    Surgery; 2016 Nov; 160(5):1288-1293. PubMed ID: 27450715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CA19-9 level determines therapeutic modality in pancreatic cancer patients with para-aortic lymph node metastasis.
    Asaoka T; Miyamoto A; Maeda S; Hama N; Tsujie M; Ikeda M; Sekimoto M; Nakamori S
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):75-80. PubMed ID: 29428109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No-touch pancreatectomy for invasive ductal carcinoma of the pancreas.
    Hirota M; Ogawa M
    JOP; 2014 May; 15(3):243-9. PubMed ID: 24865535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robotic and open distal pancreatectomy with celiac axis resection for locally advanced pancreatic body tumors: a single institutional assessment of perioperative outcomes and survival.
    Ocuin LM; Miller-Ocuin JL; Novak SM; Bartlett DL; Marsh JW; Tsung A; Lee KK; Hogg ME; Zeh HJ; Zureikat AH
    HPB (Oxford); 2016 Oct; 18(10):835-842. PubMed ID: 27506992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer.
    Hartwig W; Gluth A; Hinz U; Koliogiannis D; Strobel O; Hackert T; Werner J; Büchler MW
    Br J Surg; 2016 Nov; 103(12):1683-1694. PubMed ID: 27686238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical therapy of pancreatic cancer - 5 years survival].
    Loveček M; Skalický P; Klos D; Neoral Č; Ehrmann J; Zapletalová J; Švébišová H; Yogeswara T; Ghothim M; Vrba R; Havlík R
    Rozhl Chir; 2015 Nov; 94(11):470-6. PubMed ID: 26766155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors affecting survival after pancreaticoduodenectomy for pancreatic adenocarcinoma (single center experience).
    El Nakeeb A; El Shobary M; El Dosoky M; Nabeh A; El Sorogy M; El Eneen AA; abu Zeid M; Elwahab MA
    Hepatogastroenterology; 2014; 61(133):1426-38. PubMed ID: 25436321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.